Gilead to buy CymaBay for $4.3 billion in bets on liver disease treatment
By Bhanvi Satija (Reuters) -Gilead Sciences has agreed to buy CymaBay Therapeutics for $4.3 billion,...
N2:BIODRG
N2:BIODRG
N2:BLR
N2:CMPNY
N2:COVID
N2:DE
N2:EUROP
N2:HEA
N2:HECA
N2:HFAC
N2:HFAC1
N2:INFDIS
N2:MRCH
N2:MRCH1
N2:MTPIX
N2:NAMER
N2:NEWS1
N2:PHAG08
N2:PHAR1
N2:PHMR
N2:PUBHEA
N2:PUBL
N2:PXP
N2:RES
N2:RESF
N2:RESPIR
N2:US
N2:VACCIN
Pfizer posts surprise 4th quarter profit, but key products miss on sales
By Michael Erman and Bhanvi Satija (Reuters) -Pfizer reported a surprise quarterly profit on Tuesday,...
N2:BIODRG
N2:BLR
N2:CMPNY
N2:COMDIS
N2:COVID
N2:DE
N2:EUROP
N2:HEA
N2:HECA
N2:INFDIS
N2:MRCH
N2:MRCH1
N2:MTPIX
N2:NAMER
N2:NEWS1
N2:PHAG08
N2:PHAR1
N2:PUBHEA
N2:PUBL
N2:PXP
N2:RES
N2:RESF
N2:US
N2:VACCIN
Pfizer looks beyond COVID after quarterly loss on Paxlovid charge
By Bhanvi Satija and Michael Erman (Reuters) – Pfizer on Tuesday urged investors to focus...
N2:BIODRG
N2:CMPNY
N2:COVID
N2:DE
N2:EUROP
N2:HEA
N2:HECA
N2:HFAC
N2:HFAC1
N2:INSR
N2:MRCH
N2:MRCH1
N2:MTPIX
N2:NAMER
N2:NEWS1
N2:PHAG08
N2:PHAR1
N2:PHARWH
N2:PUBHEA
N2:PUBL
N2:RDRU
N2:RDRU1
N2:US
N2:VACCIN
New COVID shots still hard to find for some Americans
By Michael Erman and Ahmed Aboulenein NEW YORK/WASHINGTON (Reuters) – Americans have started rolling up...
N2:BIODRG
N2:CMPNY
N2:COVID
N2:DE
N2:EUROP
N2:HEA
N2:MRCH
N2:MRCH1
N2:NAMER
N2:NEWS1
N2:PHAG08
N2:PHAR1
N2:PUBHEA
N2:PUBL
N2:US
N2:VACCIN
About 4 million Americans got updated COVID vaccines in September
By Ahmed Aboulenein and Michael Erman (Reuters) -Around 4 million Americans received the updated COVID-19...
N2:BIODRG
N2:CMPNY
N2:COMDIS
N2:COVID
N2:CPROD
N2:DISEAS
N2:GEN
N2:HEA
N2:HECA
N2:HUMDIS
N2:INFDIS
N2:MEDREG
N2:MRCH
N2:NAMER
N2:PHMR
N2:PUBHEA
N2:PUBL
N2:US
N2:VACCIN
US govt awards $1.4 billion for development of new COVID therapies, vaccines
(Reuters) – The U.S. government said on Tuesday it had awarded $1.4 billion for the...